An interventional study of Phono-Motor Therapy and Semantic Feature Analysis in Stroke and Dyslexia, Acquired, sponsored by Rutgers, The State University of New Jersey. Recruiting at 3 sites in United States. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-05-06.
Sponsored by Rutgers, The State University of New Jersey · Not applicable, Interventional, and Treatment
This study is a low-risk, early phase 1, multicenter trial to test the use of a computational (neural network) cognitive model of reading to simulate acquired dyslexia and its treatment. The aim is to determine whether there is an advantage to receiving the treatment the model predicts to be advantageous compared to the alternative treatment. All participants will receive two full rounds of treatment. A round of treatment will consist of either phonomotor treatment (PMT) or semantic feature analysis (SFA) for 60 hours, distributed over 5 days a week for 2 hours a day.
7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.
This study's planned enrollment of 12 is below the median of 50 across 5,369 interventional studies indexed under Stroke.
Browse Stroke studies →Rutgers, The State University of New Jersey is the lead sponsor of 496 studies on the registry; 130 are open to participants now.
Of its 38 completed or terminated interventional studies of FDA-regulated products, 30 (79%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
This group will receive the therapy, either phonological or semantics-based, that matches the computational model prediction for the source of their reading impairment. They will receive this for the first 60 total hours of therapy, and for the second 60 hours of therapy.
Behavioral: Phono-Motor Therapy · Behavioral: Semantic Feature Analysis
This group will receive the therapy, either phonological or semantics-based, that does not match the computational model prediction for the source of their reading impairment. They will receive this for the first 60 total hours of therapy. For the second 60 hours, they will receive the other therapy.
Behavioral: Phono-Motor Therapy · Behavioral: Semantic Feature Analysis
Orthographic stimuli (letters) are introduced from the beginning as each phoneme is being trained. This maintains the focus on phonology, while emphasizing its relevance to reading. PMT consists of an initial phase focused on training of individual phonemes and phoneme sequences in spoken language, followed by written language tasks. English phonemes are first trained in isolation, followed by phoneme sequences in words and pseudowords. They are trained multi-modally through emphasis on auditory, motor, tactile-kinesthetic, visual, and orthographic representations for each consonant and vowel. When sequences are introduced, focus on phonology is maintained by training on pseudowords first before real words are introduced. Participants work on identifying, repeating, parsing, blending, and manipulating phonemes that make up the pseudoword and word stimuli. To maintain focus on phonology, pictures and definitions of the stimuli are never shown or discussed.
Also known as: PMT
SFA activates semantic features of the target word to help retrieve the spoken form of the word. To target reading, a modified SFA is used with written words rather than pictures as the primary materials. Pictures are instead included for each word as a semantic feature. Stimuli will consist of 80 highly imageable nouns with a range of word frequencies. During treatment the therapist will present a written noun and ask the participant a series of questions about the features of that noun. For example, if the presented noun is "juice", the therapist would have the participant select the corresponding picture from an array of pictures. The therapist then would ask, "what do you do with it?" (eliciting a feature from the "function" category) and "where do you store it in your home?" (eliciting a feature from the "context" category). This is done for a total of 6 categories of semantic features. The process is repeated until the participant reads the noun correctly three times in a row.
Also known as: SFA
Woodcock Reading Mastery Test - III
The WRMT-III is a standardized measure of reading skills.
Time frame: Baseline, following the first 60 hours of therapy, and following the final 60 hours of therapy.
Test words and pseudowords
Change in accuracy of reading 120 test words and 80 pseudowords
Time frame: Baseline, following the first 60 hours of therapy, and following the final 60 hours of therapy.
Western Aphasia Battery - Revised
The WAB - R is a standard measure of aphasia severity. It determines both the degree of aphasia and whether treatment has any impact on aspects of aphasia other than acquired dyslexia.
Time frame: Baseline, following the first 60 hours of therapy, and following the final 60 hours of therapy.
Comprehensive Aphasia Test - Disability Quotient
The CAT - DQ is a self-report measure of subjectively perceived degree of disability.
Time frame: Baseline, following the first 60 hours of therapy, and following the final 60 hours of therapy.
Plan to share: Yes — Pursuant to the rules of the Institutional Review Board of Rutgers, The State University of New Jersey, only data that can be fully de-identified will be shared. All data collected using non-proprietary (non-copyrighted) instruments are expected to be de-identifiable and therefore will be shared in de-identified form. These include: structural brain images (de-faced), results of the test for hemi-spatial neglect, the experimental list of 120 words and 80 pseudowords for reading aloud, and results of touch-screen choice tasks for testing phonological, semantic, and orthographic knowledge.
Supporting information: Study protocol
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rutgers, The State University of New Jersey